Tableau de bord
- Premier article le 13/02/2020
- Modérateur depuis le 10/12/2020
| Rédaction | Depuis | Articles publiés | Commentaires postés | Commentaires reçus |
|---|---|---|---|---|
| L'inscription | 14 | 690 | 427 | |
| 1 mois | 0 | 0 | 0 | |
| 5 jours | 0 | 0 | 0 |
| Modération | Depuis | Articles modérés | Positivement | Négativement |
|---|---|---|---|---|
| L'inscription | 0 | 0 | 0 | |
| 1 mois | 0 | 0 | 0 | |
| 5 jours | 0 | 0 | 0 |
Ses articles classés par : ordre chronologique
L’avocat Reiner Fuellmich en route contre l’imposture mondiale sur le coronavirus
11525 visites 3 jui. 2021 | 41 réactions |
Le médecin Gérard Maudrux interroge officiellement le médecin Olivier Veran sur son refus de guérir les malades du Covid avec l’Ivermectine
4943 visites 13 mai. 2021 | 15 réactions |
Le PDG de Pfizer a annoncé la nécessité d’un vaccin annuel. Ou l’histoire du vaccin qui fuit
2902 visites 3 avr. 2021 | 9 réactions |
L’Ivermectine pour soigner la covid : le sabordage continue
7300 visites 19 mar. 2021 | 100 réactions |
Quand est-ce qu’on ferme la démocratie ? (d’après une démonstration de Barbara Stiegler)
9531 visites 15 jan. 2021 | 22 réactions |
Monographie d’une manifestation française : celle du 12 décembre 2020 à Paris
2902 visites 5 jan. 2021 | 9 réactions |
Dr Gérard Maudrux : "les médecins ont peur, ils se taisent"
13307 visites 4 jan. 2021 | 57 réactions |
Derniers commentaires
-
@bubu12
Pauvre guignol. Un troll même pas crédible.
-
@bubu12
Vous me reprochiez de ne pas comprendre l’Anglais et maintenant, c’est à moi de vous traduire ?
L’ARN de Comirnaty et de Moderna qui va dans les différents organes, il sert à quoi ?the current data does not indicate it to be a safety concern. The relative high dose used in the rats (500x margin to human dose based on weight) also supports a low risk from distribution to the gonads in humans.
C’est pourtant au cahier de charges des deux sociétés de pharmas d’apporter la preuve que l’ARN ne quitte pas le site d’injection chez l’homme.
Vous avez la réponse ? -
@tchakpoum
Le 2ème lien concerne Moderna, c’est donc celui-ci (et non la répétition du 1er lien) :
-
@bubu12
causant des effets secondaires fréquents car leur méthode génère la production de spike dans les organes comme le cerveau, les ovaires ou le cœur au lieu de rester dans la zone d’injection
Sources ?
.Biodistribution : Several literature reports indicate that LNP-formulated RNAs can distribute rather nonspecifically to several organs such as spleen, heart, kidney, lung and brain. In line with this, results from the newly transmitted study 185350, indicate a broader biodistribution pattern with low and measurable radioactivity in the ovaries and testes. Given the current absence of toxicity in the DART data, the absence of toxicological findings in gonads in the repeat-dose studies and that the radioactivity in the gonads were low (below 0,1% of total dose), the current data does not indicate it to be a safety concern. The relative high dose used in the rats (500x margin to human dose based on weight) also supports a low risk from distribution to the gonads in humans.
.BiodistributionThe evaluation of mRNA-1273 tissue distribution was based on a rat biodistribution study using a similar mRNA-based vaccine encoding CMV antigens (mRNA-1647). The non-GLP status and no inclusion of female rats do not qualify this study as pivotal, which is not considered critical, given the general acceptance of platform approach for evaluating the toxicology profile of mRNA-1273.Following single IM injection at 100 µg mRNA-1647, the plasma and tissue pharmacokinetics and tissue distribution were assessed in blood and a pre-specified set of organs/tissues for a period of 120 hours. A qualified branched DNA (bDNA) multiplex method was used.As expected, mRNA-1647 were distributed throughout the body (including brain, heart, lung, eye, testis), and were rapidly cleared from plasma during the first 24 hours, with the T1/2 estimated in a range from 2.7 to 3.8 hours. The highest mRNA-1647 concentrations were at the injection site.Following plasma clearance, proximal and distal lymph nodes and spleen are the major distant organs to which mRNA-1647 distributes. For these highly exposed tissues, Cmax was between 2 and 24 hours post-dose, and T1/2 was 14.9 hours for muscle of site of injection, 34.8 hours for proximal lymph nodes, 31.1 hours for distal lymph nodes, and 63.0 hours for spleen. Liver distribution of mRNA-1647 was also evident, consistent with the recognised LNP distribution pattern..Même document, page 47Concentrations of mRNA-1647 were quantifiable in the majority of tissues examined at the first time point collected (2 hours post-dose) and peak concentrations were reached between 2- and 24-hours post-dose in tissues with exposures above that of plasma. Besides injection site [muscle] and lymph nodes [proximal and distal], increased mRNA concentrations (compared to plasma levels) were found in the spleen and eye. Both tissues were examined in the frame of the toxicological studies conducted with mRNA-1273 final vaccine formulation. Low levels of mRNA could be detected in all examined tissues except the kidney. This included heart, lung, testis and also brain tissues, indicating that the mRNA/LNP platform crossed the blood/brain barrier, although to very low levels (2-4% of the plasma level). Liver distribution of mRNA-1647 is also evident in this study, consistent with the literature reports that liver is a common target organ of LNPs
-
@reflexo78
Je crois que ça devient congruent : avec Omicron, ce sont les vaccinés qui sont vecteurs du virus. Ça doit être plus facile pour celui-ci de passer par des organismes abîmés par l’ARNm et les nanoparticules.
Même le New York Times (pour abonnés) a sorti les cartes pour le démontrer. Noter la Chine, sans vaccins ARNm, indemne de covid.
https://alexberenson.substack.com/p/dis-information-comes-from-the-new/comments
Agoravox utilise les technologies du logiciel libre : SPIP, Apache, Ubuntu, PHP, MySQL, CKEditor.
Site hébergé par la Fondation Agoravox
Contact / Mentions légales / Cookies et données personnelles / Charte de modération